Bayer IR Newsfeed: New on this site http://www.investor.bayer.de/ Bayer IR Newsfeed: New on this site Fri, 10 Feb 2012 03:42:17 +0100 Fri, 10 Feb 2012 03:42:17 +0100 http://www.investor.bayer.de/ en 6168_1328603448 <![CDATA[07.02.12: Events: FY/Q4 2011 Conference Call]]> http://www.investor.bayer.de/en/events/live-events/fy/q4-2011-telefonkonferenz/ Events: FY/Q4 2011 Conference Call

Investor Conference Call on February 28, 2012 at approx 2:00 p.m. CET (1:00 p.m. GMT) on the occasion of the publication of Full Year and Fourth Quarter 2011 results.

Link to website

All changes

]]> Tue, 7 Feb 2012 09:30:48 +0100 ir@bayer.com 6144_1327926823 <![CDATA[30.01.12: Stock: Consensus]]> http://www.investor.bayer.de/en/aktie/analysten/konsensus/ Stock: Consensus

New: Q4 2011 Consensus estimates

Link to website

All changes

]]> Mon, 30 Jan 2012 13:33:43 +0100 ir@bayer.com 6123_1327312104 <![CDATA[23.01.12: Events: Regorafenib Data at ASCO-GI]]> http://www.investor.bayer.de/en/events/live-events/regorafenib-daten-zu-asco-gi/ Events: Regorafenib Data at ASCO-GI

Today at approx. 12:30 p.m. CET (11:30 a.m. GMT): Investor Conference Call on Regorafenib

Link to website

All changes

]]> Mon, 23 Jan 2012 10:48:24 +0100 ir@bayer.com 6100_1326803132 <![CDATA[17.01.12: Events: Regorafenib Data at ASCO-GI]]> http://www.investor.bayer.de/en/events/live-events/regorafenib-daten-zum-asco-gi-kongress/ Events: Regorafenib Data at ASCO-GI

Results from the Phase III CORRECT study with regorafenib in patients with metastatic colorectal cancer will be presented as a late breaking abstract in an oral abstract session on January 21 (2:30 PM - 4:00 PM Pacific Time) at the 2012 Gastrointestinal Cancers Symposium of the American Society of Clinical Oncology (ASCO-GI), in San Francisco, CA, U.S. On this occasion we will hold a conference call for investors and analysts on January 23, 2012 at approx. 12:30 p.m. CET (11:30 a.m. GMT).

Link to website

All changes

]]> Tue, 17 Jan 2012 13:25:32 +0100 ir@bayer.com 5973_1321468716 <![CDATA[16.11.11: Events: China Investor Conference]]> http://www.investor.bayer.de/en/events/live-events/china-investor-conference/ Events: China Investor Conference

New: China Investor Conference on November 17, 2011

Link to website

All changes

]]> Wed, 16 Nov 2011 19:38:36 +0100 ir@bayer.com 5963_1321277356 <![CDATA[14.11.11: Events: Rivaroxaban Data at AHA 2011]]> http://www.investor.bayer.de/en/events/live-events/telefonkonferenz-aha-2011/ Events: Rivaroxaban Data at AHA 2011

New: On-demand recording of the Investor Conference Call on Rivaroxaban (presentation and discussion)

Link to website

All changes

]]> Mon, 14 Nov 2011 14:29:16 +0100 ir@bayer.com 5936_1320941193 <![CDATA[10.11.11: Bonds: EMTN Program]]> http://www.investor.bayer.de/en/anleihen/finanzierungsprogramme/emtn-programm/ Bonds: EMTN Program

New: EMTN-Supplement dated November 10, 2011

Link to website

All changes

]]> Thu, 10 Nov 2011 17:06:33 +0100 ir@bayer.com 5927_1320669758 <![CDATA[07.11.11: Events: Rivaroxaban Data at AHA 2011]]> http://www.investor.bayer.de/en/events/live-events/rivaroxaban-daten-zum-aha-kongress-2011/ Events: Rivaroxaban Data at AHA 2011

Results from the Phase III ATLAS ACS 2 TIMI 51 clinical trial of rivaroxaban (Xarelto®) have been accepted for presentation in the Late Breaking Clinical Trials Session of the American Heart Association\'s Scientific Sessions 2011. The results will be presented by C. Michael Gibson, M.S., M.D., TIMI Study Group, Boston, MA, on Sunday, November 13, from 5:13 PM - 5:23 PM (ET). On this occasion we hold a conference call for investors and analysts on November 14, 2011 at approx. 12:30 p.m. CET (11:30 a.m. GMT).

Link to website

All changes

]]> Mon, 7 Nov 2011 13:42:38 +0100 ir@bayer.com 5897_1319704069 <![CDATA[27.10.11: Handouts: Investor Handout]]> http://www.investor.bayer.de/en/handouts/investor-handout/ Handouts: Investor Handout

New: Presentation Charts for Q3 2011 Investor Conference Call

Link to website

All changes

]]> Thu, 27 Oct 2011 10:27:49 +0200 ir@bayer.com 5875_1319691165 <![CDATA[27.10.11: Events: Q3 2011 Conference Call]]> http://www.investor.bayer.de/en/events/live-events/q3-2011-telefonkonferenz/ Events: Q3 2011 Conference Call

Live Today: Q3 2011 Investor Conference Call at 1:00 p.m. CEST (11:00 a.m. GMT)

Link to website

All changes

]]> Thu, 27 Oct 2011 06:52:45 +0200 ir@bayer.com 5870_1319688994 <![CDATA[27.10.11: Reports: Quarterly Reports]]> http://www.investor.bayer.de/en/berichte/quartalsberichte/ Reports: Quarterly Reports

New: Financial Report as of September 30, 2011

Link to website

All changes

]]> Thu, 27 Oct 2011 06:16:34 +0200 ir@bayer.com 5858_1319533838 <![CDATA[25.10.11: Stock: Share Listings]]> http://www.investor.bayer.de/en/aktie/listing-und-kennzahlen/börsenplätze/ Stock: Share Listings

Update: Delisting London

Link to website

All changes

]]> Tue, 25 Oct 2011 11:10:38 +0200 ir@bayer.com 5849_1319017362 <![CDATA[19.10.11: Stock: Consensus]]> http://www.investor.bayer.de/en/aktie/analysten/konsensus/ Stock: Consensus

New: Q3 2011 Consensus estimates

Link to website

All changes

]]> Wed, 19 Oct 2011 11:42:42 +0200 ir@bayer.com 5835_1318321264 <![CDATA[11.10.11: Events: Q3 2011 Conference Call]]> http://www.investor.bayer.de/en/events/live-events/q3-2011-telefonkonferenz/ Events: Q3 2011 Conference Call

New: Bayer will host a conference call for investors and analysts on October 27, 2011 at approx. 1:00 p.m. CEST (11:00 a.m. GMT), to review third quarter 2011 results.

Link to website

All changes

]]> Tue, 11 Oct 2011 10:21:04 +0200 ir@bayer.com 5817_1317331801 <![CDATA[29.09.11: News: Ad-hoc Publications]]> http://www.investor.bayer.de/en/news/ad-hoc-mitteilungen/ News: Ad-hoc Publications

New: Ad-hoc Announcement as of September 29, 2011

Link to website

All changes

]]> Thu, 29 Sep 2011 23:30:01 +0200 ir@bayer.com